Heart Institute Cardiologists
Dr. Do has a special interest in outcomes research for patients in the CVICU in addition to looking at markers to predict liver dysfunction in single ventricle patients post Fontan palliation.
Dr. El-Said’s research interest include 3-D angiography to facility catheterization procedures, modifying stents to suit growing children, percutaneous valve development, innovative interventional techniques to avoid surgery, adult congenital Fontan patients and bioengineering of special wires to facilitate cath procedures.
Dr. Fagan’s research includes investigation of Ebstein’s anomaly of the tricuspid valve.
Dr. Narayan’s research is focused on the cardiotoxic effects of cancer therapies. He is interested in characterizing the natural history and risk factors for the development of cardiomyopathy after cancer therapy and determining the optimal diagnostic and management strategies for this disease.
Dr. Perry is interested in clinical and translational research projects on antiarrhythmic drugs, catheter ablation, adult congenital heart arrhythmias, computational modeling of congenital heart disease, innovative device designs, bioengineering and electrophysiology, cardiac genomics and channelopathies.
Dr. Pour Molkara research interests include fetal cardiac anomalies, neonatal coronary artery thrombus and preventive cardiology.
Dr. Williams has clinical and research interests related to the diagnosis and management of cardiac rhythm disturbances from fetal to adult life, including non-invasive and invasive monitoring and diagnostic techniques, antiarrhythmic medications, catheter-based therapies for arrhythmias, heritable arrhythmia syndromes, rhythm disturbances associated with congenital heart disease and pacemaker and ICD implantation and programming.
Dr. Yeh’s clinical and research interests are pediatric mechanical circulatory support, in particular the application of ventricular assist devices to support patients with refractory heart failure. His research also involves the use of erythropoietin to reduce transfusion burden and improve the care of patients with cyanotic congenital heart disease.
Dr. Lamberti’s clinical and research interests are focused on the surgical treatment of congenital heart disease in infants, children and adults of all ages.
Dr. Murthy’s clinical and research interests are focused on surgical management of congenital heart disease in people of all age groups, complex neonatal and infant heart surgery, robotics in thoracic surgery, mechanical assist devices and transplantation of thoracic organs.
Dr. Nigro’s research interests include outcome analysis, especially for patients with hypoplastic left heart syndrome, cerebral blood flow and 3-D simulation and imaging.